Brief Intervention Study for Quitting Smoking

NCT ID: NCT01589211

Last Updated: 2022-09-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

347 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-12-16

Study Completion Date

2013-04-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To investigate the effectiveness of a smoking cessation intervention of two sessions (120 min at a time) in a group setting on the basis of Motivational Interviewing (MI) and important elements of Cognitive Behavioural Therapy (CBT). According to national and international guidelines patients are advised to quit and pharmacologically supported with one of the established first line smoking cessation treatments.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study design is multicentric, prospective, randomized and controlled. The study is taking place in cooperation with smoking clinics of 5 centres in Germany (Heidelberg, Stuttgart, Munich, Chemnitz, Berlin). A total number of 800 smokers is calculated to participate in the study. After enrollment participants are randomized in one of the three intervention groups: (A) "Advice only", (B) "Brief intervention", (C) "Intensive therapy". The follow up includes a telephone interview 3 months after the last intervention, and two visits at the smoking clinics after 6 and 12 months with biochemical validation of the smoking status by measurement of the exhaled carbon monoxide and the concentration of cotinine in an urine sample respectively. The primary endpoint is the continuous abstinence rate after 12 months. Several secondary endpoints are determined amongst others the continuous abstinence rate after 6 months, point prevalence cessation rates after 6 and 12 months, life quality, weight gain, predictors of a successful cessation attempt.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Smoking Tobacco Use Cessation Smoking Cessation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Brief advice

A brief advice to stop smoking of about 10 min accompanied with self-help material

Group Type ACTIVE_COMPARATOR

Brief advice

Intervention Type BEHAVIORAL

Brief advice of about 10 min accompanied by self-help material

Compact cessation course

Cessation intervention of 2 x 120 min in a group setting

Group Type EXPERIMENTAL

Compact cessation course

Intervention Type BEHAVIORAL

Compact cessation course on the basis of Motivational Interviewing (MI) and Cognitive Behavioural Therapy (CBT). Group setting. 2 x 120 min.

Standard cessation course

Cessation course in a group setting over 6 dates

Group Type ACTIVE_COMPARATOR

Standard cessation course

Intervention Type BEHAVIORAL

Cessation course over 6 dates. Group setting.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Brief advice

Brief advice of about 10 min accompanied by self-help material

Intervention Type BEHAVIORAL

Compact cessation course

Compact cessation course on the basis of Motivational Interviewing (MI) and Cognitive Behavioural Therapy (CBT). Group setting. 2 x 120 min.

Intervention Type BEHAVIORAL

Standard cessation course

Cessation course over 6 dates. Group setting.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Smoker
* Age \> 18 years
* Motivation to quit smoking

Exclusion Criteria

* severe somatic comorbidity or reduced life expectancy
* severe episode of a psychiatric disease
* reduced cognitive ability
* abuse of alcohol or illicit drugs
* other reasons at the discretion of responsible local study tutor
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pfizer

INDUSTRY

Sponsor Role collaborator

Heidelberg University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Felix JF Herth

Dr. med. Alexander Rupp

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alexander Rupp, Dr.

Role: PRINCIPAL_INVESTIGATOR

Heidelberg University

Michael Kreuter, PD Dr.

Role: STUDY_CHAIR

Heidelberg University

Felix JF Herth, Prof.

Role: STUDY_DIRECTOR

Heidelberg University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Thoraxklinik Heidelberg

Heidelberg, Baden-Wurttemberg, Germany

Site Status

Pneumologische Praxis im Zentrum (former: Zentrum für Tabakentwöhnung Stuttgart)

Stuttgart, Baden-Wurttemberg, Germany

Site Status

Klinikum der Universität München - Klinik für Psychiatrie und Psychotherapie

Munich, Bavaria, Germany

Site Status

Technische Universität Chemnitz - Institut für Psychologie

Chemnitz, Saxony, Germany

Site Status

Institut für Raucherberatung und Tabakentwöhnung am Gemeinsschaftskrankenhaus Havelhöhe

Berlin, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

References

Explore related publications, articles, or registry entries linked to this study.

Rupp A, Blank J, Ehmann M, Pousset R, Mühlig S, Sehl A, Fuchs S, Rüther T, Linhardt A, Grah C, Kreuter M. Basic data of the Brief Intervention Study for Quitting Smoking (BISQUITS). Pneumologie. 2014; 68 - P106 DOI: 10.1055/s-0034-1367889

Reference Type BACKGROUND

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

WS899101

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Tobacco Cessation Intervention
NCT03657511 COMPLETED NA
Smoking Cessation in Alcoholics
NCT00963482 COMPLETED NA
Smoking Cessation Intervention
NCT03072511 TERMINATED PHASE4